Organovo Holdings Inc (NASDAQ:ONVO)
| 1.59 Delayed Data As of Jan 26 |  +0.01 / +0.63%Today’s Change | 1.37 Today|||52-Week Range 4.67 | +12.77% Year-to-Date |
Latest ONVO News | Press Releases
No recent news for Organovo Holdings Inc.
Today’s Trading
| Previous close | 1.58 |
| Today’s open | 1.58 |
| Day’s range | 1.53 - 1.60 |
| Volume | 20,081 |
| Average volume (3 months) | 25,421 |
| Market cap | $14.2M |
Data as of 3:19pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | +46.05% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 21.82 |
| Price/Book | 0.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NDRAENDRA Life Sciences ... | -0.10 | -2.41% |
| GENEGenetic Technologies... | -0.05 | -5.28% |
| ITRMIterum Therapeutics ... | -0.01 | -0.83% |
| CANFCan Fite Biopharma L... | +0.16 | +3.95% |
Data as of 3:59pm ET, 01/26/2023
Financials
| Last reporting date | June 10, 2020 |
| EPS forecast (this quarter) | -$1.00 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -763.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
